Dextenza
Showing 1 - 25 of 44
Steroid Ophthalmic Insert Trial (Dextenza 0.4Mg Ophthalmic Insert, Topical Fluorometholone)
Not yet recruiting
- Steroid Ophthalmic Insert
- Dextenza 0.4Mg Ophthalmic Insert
- Topical Fluorometholone
- (no location specified)
Oct 17, 2022
Vitreoretinopathy, Coats' Disease, Exudative Retinopathy Trial in Durham (Dextenza 0.4Mg Ophthalmic Insert, Pred Forte)
Not yet recruiting
- Vitreoretinopathy
- +8 more
- Dextenza 0.4Mg Ophthalmic Insert
- Pred Forte
-
Durham, North CarolinaDuke Eye Center
Nov 10, 2022
Corneal Edema, Corneal Defect, Anterior Chamber Inflammation Trial in Los Angeles (Dextenza 0.4Mg Ophthalmic Insert,
Not yet recruiting
- Corneal Edema
- +6 more
- Dextenza 0.4Mg Ophthalmic Insert
- +3 more
-
Los Angeles, CaliforniaAdvanced Vision Care
Dec 5, 2022
Pterygium of Both Eyes Trial in Brandon (Intracanalicular Dexamethasone, (0.4 mg) Insert, Prednisolone Acetate)
Active, not recruiting
- Pterygium of Both Eyes
- Intracanalicular Dexamethasone, (0.4 mg) Insert
- Prednisolone Acetate
-
Brandon, FloridaBrandon Eye Associates
Jul 19, 2022
Bilateral Conjunctivitis (Disorder) Trial in Pompano Beach (Dexamethasone ophthalmic insert 0.4Mg, 0.2% loteprednol etabonate
Completed
- Bilateral Conjunctivitis (Disorder)
- Dexamethasone ophthalmic insert 0.4Mg
- +2 more
-
Pompano Beach, FloridaClinical Research Center of Florida
Apr 6, 2022
Glaucoma, Cataract Trial in Bronx (Dexamethasone Ophthalmic Insert, Prednisolone Acetate 1% Oph Susp)
Recruiting
- Glaucoma
- Cataract
- Dexamethasone Ophthalmic Insert
- Prednisolone Acetate 1% Oph Susp
-
Bronx, New YorkThe New York Eye Surgery Center
Mar 20, 2022
Cataract Trial in Dayton (Dextenza 0.4Mg Ophthalmic Insert)
Completed
- Cataract
- Dextenza 0.4Mg Ophthalmic Insert
-
Dayton, OhioIworks Laser & Vision Center
Dec 22, 2022
Pterygium Trial in New York (Dexamethasone Intracanalicular Insert, 0.4mg, Prednisolone Acetate 1%)
Completed
- Pterygium
- Dexamethasone Intracanalicular Insert, 0.4mg
- Prednisolone Acetate 1%
-
New York, New YorkNew York Eye Specialists
Apr 4, 2022
Graft Vs Host Disease Trial in Boston (DEXTENZA (dexamethasone ophthalmic insert) 0.4 mg, for intracanalicular use, Regular
Withdrawn
- Graft Vs Host Disease
- DEXTENZA (dexamethasone ophthalmic insert) 0.4 mg, for intracanalicular use
- Regular dissolvable intracanalicular plug
-
Boston, MassachusettsMass Eye and Ear
Dec 14, 2021
Glaucoma Following Surgery Trial in Memphis (DEXTENZA, Topical Dexamethasone)
Not yet recruiting
- Glaucoma Following Surgery
- DEXTENZA
- Topical Dexamethasone
-
Memphis, TennesseeHamilton Eye Institute
Nov 9, 2021
Cataract Trial (Dextenza 0.4Mg Ophthalmic Insert, Topical Prednisolone)
Not yet recruiting
- Cataract
- Dextenza 0.4Mg Ophthalmic Insert
- Topical Prednisolone
- (no location specified)
Aug 25, 2021
Vitreoretinal Surgery, Ocular Inflammation, Post-operative Pain Trial in Cleveland (Dexamethasone Ophthalmic Insert,
Enrolling by invitation
- Vitreoretinal Surgery
- +3 more
- Dexamethasone Ophthalmic Insert
- Prednisolone Acetate 1% Oph Susp
-
Cleveland, OhioCole Eye Institute, Cleveland Clinic
Feb 24, 2022
Cataract Trial in Northbrook (Dextenza 0.4Mg Ophthalmic Insert, Prednisolone Acetate 1%)
Enrolling by invitation
- Cataract
- Dextenza 0.4Mg Ophthalmic Insert
- Prednisolone Acetate 1%
-
Northbrook, IllinoisWyse Eyecare
Jan 17, 2023
Cataract Diabetic, Macula Edema Trial (Dextenza 0.4Mg Ophthalmic Insert, Prednisolone Acetate 1% Oph Susp)
Not yet recruiting
- Cataract Diabetic
- Macula Edema
- Dextenza 0.4Mg Ophthalmic Insert
- Prednisolone Acetate 1% Oph Susp
- (no location specified)
Jul 15, 2021
Dry Eye Trial in Baltimore (Sustained Release Dexamethasone, 0.4 mg, E-Caprolactone-L-Lactide copolymer (PCL) punctal plug)
Recruiting
- Dry Eye
- Sustained Release Dexamethasone, 0.4 mg
- E-Caprolactone-L-Lactide copolymer (PCL) punctal plug
-
Baltimore, MarylandWilmer Eye Institute, Johns Hopkins School of Medicine
Jan 24, 2022
Post Procedural Infection Trial in Brecksville (Dexamethasone ophthalmic insert 0.4 mg)
Completed
- Post Procedural Infection
- Dexamethasone ophthalmic insert 0.4 mg
-
Brecksville, OhioCleveland Eye Clinic
Jul 26, 2021
DEXTENZA 0.4 mg inseRt Following Corneal Transplant or Cataract
Completed
- Anterior Chamber Inflammation
- +7 more
- Dextenza 0.4Mg Ophthalmic Insert
-
Los Angeles, CaliforniaAdvanced Vision Care
Jul 14, 2021
Cataract Trial (Dexamethasone 0.4 MG [Dextenza])
Not yet recruiting
- Cataract
- Dexamethasone 0.4 MG [Dextenza]
- (no location specified)
Nov 22, 2021
Ocular Rosacea Trial (Dextenza 0.4Mg Ophthalmic Insert, Fluoromethalone .01%)
Not yet recruiting
- Ocular Rosacea
- Dextenza 0.4Mg Ophthalmic Insert
- Fluoromethalone .01%
- (no location specified)
Apr 8, 2021
Dry Eye Syndromes Trial in Racine (Dextenza 0.4Mg Intracanalicular Insert, Over the counter Artificial tears)
Completed
- Dry Eye Syndromes
- Dextenza 0.4Mg Intracanalicular Insert
- Over the counter Artificial tears
-
Racine, WisconsinThe Eye Center of Racine
Apr 21, 2022
Ocular Disease Requiring Surgery Trial in Paso Robles, San Luis Obispo, Santa Maria (DEXTENZA®)
Not yet recruiting
- Ocular Disease Requiring Surgery
-
Paso Robles, California
- +2 more
Jan 28, 2021
Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion Trial in Saint Petersburg (Dextenza
Recruiting
- Neovascular Age-related Macular Degeneration
- +2 more
- Dextenza 0.4Mg Ophthalmic Insert
- Prednisolone Acetate
-
Saint Petersburg, FloridaRetina Vitreous Associates of Florida
Mar 10, 2021